Hudson River Biotechnology is an innovation-oriented company, with many brilliant scientists in the team. So how do we create an environment where our scientists can perform necessary project tasks, enjoy their work, AND have the time and energy to innovate? Our Innovation & Automation managers, Kitty Huijben & Judit Hunyadkürti wrote down what we’re doing at HRB to make […]
March 15, Wageningen – To combat the current issues prevalent in field crop care, HRB and SE collaborated on PlentranceTM: a targeted, biodegradable particle for crop inputs, which can uniquely penetrate the plant cell wall and deliver cargo inside plant cells. Ferdinand Los (CSO): “Originally tailored for CRISPR delivery as part of TiGER genome editing […]
Prof. Enrico Mastrobattista joins Hudson River Biotechnology’s Scientific Advisory Board and will advise on nanoparticle delivery
Professor Enrico Mastrobattista, full professor of Pharmaceutical Biotechnology & Delivery at the department of Pharmaceutical Sciences of Utrecht University, joins the Scientific Advisory Board of Hudson River Biotechnology (HRB). Prof. Mastrobattista’s expertise lies in drug delivery, pharmaceutical biotechnology and nanobiotechnology. He currently leads a research program to develop biomimetic drug delivery systems for the targeted […]
Computomics and Hudson River Biotechnology (HRB) will start offering AccelATrait™, a joint end-to-end solution using CRISPR-based gene editing for novel plant trait development. AccelATrait™ uses tailormade machine learning and CRISPR gene editing technologies to deliver new crop varieties with desired traits. AccelATrait™ covers the entire workflow from experimental design to plant regeneration. It helps plant […]
Prof. Patricia Dankers, full professor of Biomedical Materials & Chemistry at the department of Biomedical Engineering and the Institute for Complex Molecular Systems of Eindhoven University of Technology, has joined the Scientific Advisory Board of Hudson River Biotechnology (HRB). Prof. Dankers is internationally renowned for her fundamental research on supramolecular biomaterials for regenerative medicine applications. […]
Hudson River Biotechnology raises €5m Series A funding to accelerate growth of its plant gene editing business and expand into nanoparticles for use in field applications
Ferdinand Los, CSO at Hudson River Biotechnology: “We strongly believe in our ability to keep innovating and be at the forefront of technological developments. This funding is another building block, which will allow us to further scale up the existing gene editing business.” Additionally, HRB will grow its staff count from 25 to 40 in […]
In an opinion piece on AgFunder, our founders Rudi Ariaans and Ferdinand Los argue that CRISPR is the best tool the EU has to achieve its ambitious agrifood sustainability goals. The bloc needs to keep that squarely in mind when regulating its use. Read the article here.
Bionieuws, the Dutch magazine for biologists interviewed our CSO Ferdinand Los, and published a short company profile in their magazine. Read the article here.
Prof. John van der Oost, head of the Bacterial Genetics group in the Laboratory of Microbiology at Wageningen University, has joined the Scientific Advisory Board of Hudson River Biotechnology (HRB). Prof. van der Oost is considered a pioneer of the “CRISPR revolution” for his fundamental work on unravelling the mechanism of CRISPR-based immunity in bacteria, […]